Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10968590 | Vaccine | 2011 | 8 Pages |
Abstract
⺠The ACIP no longer recommends routine PPSV23 use for all AI/AN persons <65 years. ⺠We examine the rationale for this change. ⺠Certain AI/AN populations continue to suffer higher IPD rates than the general U.S. population. ⺠Much of the excess burden occurs among those with an existing vaccine indication.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Maria A. Said, Katherine L. O'Brien, J. Pekka Nuorti, Rosalyn Singleton, Cynthia G. Whitney, Thomas W. Hennessy,